Geometry Dash APK Hill Climb Racing APK
69.7 F
New York
Monday, September 26, 2022

Northwest Biotherapeutics, Inc (OTCMKTS:NWBO) Witnesses Bullish Momentum

Must read

Net Savings Link Inc (OTCMKTS:NSAV) Goes Parabolic Ahead of Important Event

As far as cryptocurrency and blockchain companies are concerned, there are many options nowadays for investors to explore.

American Diversified Holdings Corp (OTCMKTS:ADHC) Nears Critical Level

When a stock records significant gains and then crashes and repeats over the course of a few months, then it might be...

Reconnaissance Energy Africa Ltd (OTCMKTS:RECAF) Gathers Further Momentum

If you are currently looking for stocks that may have recorded massive gains within a short period of time, then it might...

Humbl Inc (OTCMKTS:TSNPD) Bounces Back and Lands On The Radar

Over the course of the past months, Humbl Inc (OTCMKTS:TSNPD) stock has managed to record massive gains and much of that has...

One of the notable movers among biotech stocks of 2020 has been Northwest Biotherapeutics, Inc (OTCMKTS:NWBO), and last week, the stock was on another of its classic runs.

Last week Northwest Biotherapeutics, Inc (OTCMKTS:NWBO) rallied by as much as 30%, and in that sort of situation; it could be worthwhile for investors to perhaps take a closer look at the stock which now sits at $1.76.

Key Factors to Watch

Currently, the stock seems to be rising on the back of feverish speculation with regards to the data from the Phase 3 trial of its product DCVax®-L. Investors are clearly lying wait for the results. More importantly, the trading volume in the Northwest stock went up considerably last week as well.

It seems that there is speculation among investors that the company could be on the verge of actually succeeding in a field in which many other companies have failed. The product in question is meant for treating Gliobastoma, which is regarded as one of the most medicine resistant variants of cancer.

It is quite deadly as well for patients and over the years some of the biggest names from the world of biotech and pharmaceuticals industry have failed. The data from the trial will end a wait that has gone on for as long as 13 years for investors.

On the other hand, it is also important to consider the potential market size when it comes to Gliobastoma treatment. It has been suggested that the total size of the market for the treatment of the cancer variant could be as much as $1.4 billion by 2025. In addition to that, Northwest’s product has also got a lot of attention from the mainstream media this year so far and that has only raised the level of anticipation among investors.

The product clearly has potential and it could be quite worthwhile for investors to keep a keen eye on the developments around the product in the coming days.

Disclaimer: We hold no position in NWBO stock.

Latest article

Alibaba Group Holding Limited (OTCMKTS:BABAF) Big Volume with Possible 60% Upside

Alibaba Group Holding Limited (OTCMKTS:  BABAF) is an over the counter stock traded on the OTC Pink markets in the Consumer Discretionary...

Trans Global Group Inc (OTCMKTS:TGGI) Stock In Focus After Operational Updates

The Trans Global Group Inc (OTCMKTS:TGGI) stock may not have been in the news today yet but it...

Why Hycroft Mining (NASDAQ:HYMC) Stock Shot Up 700%

If you are on the hunt for stocks that may have made major gains over the course of the past week, then...

Secure Paymentz releases banking software demo on Github

This is a paid announcement from one of our advertising partners. How to Leverage Your Trading Position by Secure...

Advanced Asset Management Announces New Website Launch

This is a paid announcement from one of our advertising partners. Financial Planner in Grandville, Michigan
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service